I am a biochemist with a solid background in biomedical research, including cancer biology and innate immunity. I have experience in many different biochemical research methods, from in situ hybridization to quantitative LC-MS/MS-based proteomics.
My current work is focused on understanding the mechanisms of pathogenesis and drug resistance in hematological malignancies, more specifically in multiple myeloma (MM) and acute myeloid leukemia (AML). This research requires the combination of high throughput drug sensitivity and resistance testing, NGS, and quantitative proteomics. Aims of the work are to identify new treatment strategies for patients with recurrent disease, identify new biom...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
